CURRICULUM VITAE. (713) (O) B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974

Similar documents
Multicenter Study of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Publications

De.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): N/A

CURRICULUM VITAE ROBERT JACKSON HARDY. Date of Birth: October 27, 1940 Place of Birth: Alexandria, Louisiana

Screening Examination of Premature Infants for Retinopathy of Prematurity

INFANTS WITH birth weights less

Downloaded from journal.gums.ac.ir at 15:41 IRST on Friday February 22nd 2019

Pulsed mode versus near-continuous mode delivery of diode laser photocoagulation for high-risk retinopathy of prematurity

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP) (REPRINTED) ARCH OPHTHALMOL / VOL 125 (NO.

Criteria for the timing of the initial retinal examination to screen for retinopathy of prematurity

FINAL RESULTS OF THE EARLY TREATMENT FOR RETINOPATHY OF PREMATURITY (ETROP) RANDOMIZED TRIAL

10. ADVANCED RETINOPATHY OF PREMATURITY

Argon laser photocoagulation for retinopathy of prematurity: long-term outcome

ALTHOUGH EARLY TREATment

Classification of ROP

Non-ophthalmologist screening for retinopathy of prematurity

Retinopathy of prematurity (ROP) is a disorder of retinal

Screening Examination of Premature Infants for Retinopathy of Prematurity

R etinopathy of prematurity (ROP), a condition confined

Study of Incidence, Clinical Staging and Risk Factors of Retinopathy of Prematurity in Rural Area

TELLER ACUITY CARDS UPDATE 8/04 NAME: ADDRESS: ADDRESS: CITY: STATE: ZIP CODE: TELEPHONE:

Retinopathy of Prematurity. Objectives. Normal Retina Development. ROP Pathogenesis 6/8/2018. Thomas W. Hejkal, MD, PhD Eye Consultants, PC

Laser Therapy Versus Anti-VEGF Agents for Treatment of Retinopathy of Prematurity. Ilya Leskov, MD, PhD Shizuo Mukai, MD

Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser

RETINOPATHY OF PREMATUrity

Retinopathy of prematurity: clinical aspects

Screening for retinopathy of prematurity at Cipto Mangunkusumo Hospital, Jakarta, Indonesia a preliminary report

OUTCOMES AFTER LASER VERSUS COMBINED LASER AND BEVACIZUMAB TREATMENT FOR TYPE 1 RETINOPATHY OF PREMATURITY IN ZONE I

Color Vision Measured With Pseudoisochromatic Plates at Five-and-a-Half Years in Eyes of Children From the CRYO-ROP Study

Treatment of retinopathy of prematurity

The New England Journal of Medicine LACK OF EFFICACY OF LIGHT REDUCTION IN PREVENTING RETINOPATHY OF PREMATURITY

Diode Laser Photocoagulation for Retinopathy of Prematurity: Outcomes After 7 Years of Treatment

Original Article Refractive status and optical components in premature babies with and without retinopathy of prematurity at 5 years old

EarlyTreatment ROP Study: How It Affects My Practice

CURRICULUM VITAE. EDUCATION: B.S., Life Sciences Massachusetts Institute of Technology Cambridge, Massachusetts

Clinical Study Macular Development in Aggressive Posterior Retinopathy of Prematurity

Archive of SID. Downloaded from jmums.mazums.ac.ir at 2: on Monday October 8th

Prematurity, the Eye and Vision

Visual Impairment & Eye Health in Children. Susan Cotter, OD, MS So CA College of Optometry Marshall B Ketchum University Fullerton, CA

Original Article Refractive status and optical components of premature babies with or without retinopathy of prematurity at 3-4 years old

Clinical Study Incidence of Retinopathy of Prematurity in Extremely Premature Infants

Distribution of Retinopathy of Prematurity and Its Risk Factors

CLINICAL SCIENCES. Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management

Childhood blindness due to ROP

PCMCH ROP Screening Guidelines

The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants 1

NIH Public Access Author Manuscript J AAPOS. Author manuscript; available in PMC 2006 April 25.

Grand Rounds. Jenny Temnogorod SUNY Downstate Medical Center Department of Ophthalmology September 19, 2013

Blood Gases And Retinopathy Of Prematurity: The Extremely Low Gestational Age Newborn Study

REFRACTIVE OUTCOMES OF THREE-PORT LENS-SPARING VITRECTOMY FOR RETINOPATHY OF PREMATURITY (AN AOS THESIS)

Late-onset Retinal Detachment Associated with Regressed Retinopathy of Prematurity

Universal Newborn Eye Screening

The prevalence of anisometropia aniso-astigmatism and amblyopia in neurofibromatosis type 1

CURRICULUM VITAE DEREK T. SPRUNGER Degree: B.S. Summa Cum Laude Degree: M.D. Residency: Ophthalmology

Long term follow up of premature infants: detection of strabismus, amblyopia, and refractive errors

A bs tr ac t. n engl j med 364;7 nejm.org february 17,

CLINICAL TRIALS. SECTION EDITOR: ANNE S. LINDBLAD, PhD. Grating Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study

Research Article Association of Birth Parameters with Refractive Status in a Sample of Caucasian Children Aged 4 17 Years

Structural outcomes of eyes with threshold retinopathy of prematurity treated with laser therapy or cryotherapy

Retinopathy of Prematurity: A Visually Impairing Disorder Name English 12 Section 35 Professor Marchbanks September 29, 2005

RETINOPATHY OF PREMATURITY: LATE COMPLICATIONS IN THE BABY BOOMER GENERATION ( )

MEDICAL POLICY SUBJECT: OCULAR PHOTOSCREENING. POLICY NUMBER: CATEGORY: Technology Assessment

Cumulative illness severity and progression from moderate to severe retinopathy of prematurity

Controversies in Pediatric Refractive Development Timothy Hug, OD, FAAO

LONG-TERM VISUAL OUTCOMES IN EXTREMELY LOW-BIRTH-WEIGHT CHILDREN (AN AMERICAN OPHTHALMOLOGICAL SOCIETY THESIS)

Comparison of Recognition and Grating Acuities in * Very-Low-Birth-Weight Children With and Without,, Retinal Residua of Retinopathy of Prematurity

Jiao Lyu 1, Qi Zhang 1, Chunli Chen 2,YuXu 1, Xunda Ji 1 and Peiquan Zhao 1*

Pros and Cons in the use of AntiVEGF therapy in ROP

When & how to Rx glasses in children

Antivascular endothelial growth factor for retinopathy of prematurity Helen A. Mintz-Hittner a and Leah M. Best b

Early Human Development

Dordi Austeng, Department of Neuroscience, Box 593, Uppsala University, SE Uppsala, Sweden

Outcome of the Treatment of Retinopathy of Prematurity in Qatar

ROP and Imaging. Deborah M Costakos MD, MS August 12, 2016

Outcome of Cataract Surgery in Patients Treated for Retinopathy of Prematurity

Factors Influencing the Prevalence of Amblyopia in Children with Anisometropia

CURRICULUM VITAE LORY CECILIA SNADY-McCOY, M.D.

One-Year Strabismus Outcomes in the Infant Aphakia Treatment Study

How Often Are Spectacles Prescribed to Normal Preschool Children?

Lessons learned about cataract surgery in infants from the Infant Aphakia Treatment Study

Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants

RETINOPATHY OF PREMATURITY (ROP) IS A RETINAL

PMA Weight (g) Diagnosis at IVB. at IVB

Former Director/Lead Trainer Vision Initiative for Children West Virginia University Eye Institute

Kathryn L. Pepple, MD, PhD

Reviews in Clinical Medicine

Comparison of Ocular and Developmental Outcomes in Laser-and Bevacizumab-treated Infants with Retinopathy of Prematurity

Former Director/Lead Trainer Vision Initiative for Children West Virginia University Eye Institute

Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia

Recurrence of ROP after Anti-VEGF Therapy: How Many, Which Ones, When, What, Where

CLINICAL SCIENCES. The CHOP Postnatal Weight Gain, Birth Weight, and Gestational Age Retinopathy of Prematurity Risk Model

Early retinopathy of prematurity findings identified with fluorescein angiography

Ocular Assessment. Materials and Methods

Late clinical characteristics of infants with retinopathy of prematurity and treated with cryotherapy

Binocular Vision and Stereopsis Following Delayed Strabismus Surgery

Rango de saturacion de oxigeno: Cual es la evidencia?

Ultrasonographic Findings in Eyes with Retinopathy of Prematurity in Malaysia

Surgical Results and Visual Outcomes of Vitreous Surgery for Advanced Stages of Retinopathy of Prematurity

Transcription:

CURRICULUM VITAE NAME: Betty P. Tung BIRTH DATE: November 23, 1951 OFFICE (713) 500-9549(O) Betty.p.tung@uth.tmc.edu EDUCATIONAL BACKGROUND: B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974 M.S. in Biometry, University of Texas School of Public Health, Texas, 1977 PROFESSIONAL EXPERIENCE 1979 - Present Faculty Associate, The University of Texas School of Public Health Coordinating Center for Clinical Trials, Houston, Texas. 2000 - Present Project Manager/Statistician, Coordinating Center of Early Treatment for Retinopathy of Prematurity. 1995-2000 Project Manager/Statistician, Coordinating Center of Feasibility Trial of Light Reduction for Retinopathy of Prematurity. 1985-2005 Project Manager/Statistician, Coordinating Center of Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. 1983-1985 Teaching Assistant, Biostatistics, Regression Analysis, The University of Texas School of Public Health, Houston, Texas. 1979-1985 Statistician for the Hypertension Detection and Follow-up Program, plan and carry out data analyses for both internal use and for publication, prepare and present study reports 1977-1979 Statistician and Programmer Analyst, The University of Texas School of Public Health, Lipid Research Project, Houston, Texas.

Page 2 1975-1977 Research Statistical Aid, The University of Texas School of Public Health, Lipid Research Project, Houston, Texas. Department of Epidemiology. -- Compilation and summary in both tabular arrangement and graphic form for lipid data. 1974-1975 Technician, National Defense Medical Center, Taiwan, R.O.C. -- Microcomplement fixation test, immuno-electrophoresis data checking. HONORS: Four-year Scholarship in College PUBLICATIONS: Curb JD, Babcock C, Pressel S, Tung B, Remington RD, Hawkins CM: Nosological Coding of Cause of Death. American Journal of Epidemiology 118(1):122-128, 1983. Langford H, Oberman A, Borhani N, Entwisle G, Tung B: Black-White Comparison of Indices of Coronary Heart Disease and Myocardial Infarction in the Stepped Care Cohort of the Hypertension Detection and Follow-up Program. American Heart Journal 108(3) part 2:797-801, 1984. Hypertension Detection and Follow-up Program Cooperative Research Group: The Effect of Antihypertensive Drug Treatment on Mortality in the Presence of Resting Electrocardiographic Abnormalities at Baseline: The HDFP Experience. Circulation 70(6):996-1003, 1984. Curb JD, Borhani N, Entwisle G, Tung B, Kass E, Schnaper H, March Williams W, Berman R: Isolated Systolic Hypertension in 14 Communities. American Journal of Epidemiology 121(3):362-370, 1985. Davis B, Curb JD, Tung B, Hawkins CM, Ehrman S, Farmer J, Martin M: Standardized Physician Preparation of Death Certificates. Controlled Clinical Trials 8:110-120, 1987. Hypertension Detection and Follow-up Program Cooperative Research Group: Education Level and 5-Year All-Cause Mortality in the Hypertension Detection and Follow-up Program. Hypertension Vol 9, No. 6, June 1987.

Page 3 Prematurity--Preliminary results. Archives of Ophthalmology 106:471-479, 1988. (also in Pediatrics 81(5):697-706, 1988) Prematurity--Three Month Outcome. Archives of Ophthalmology 108:195-204, 1990. Dobson V, Quinn GE, Biglan AW, Tung B, Flynn JT, Palmer EA: Acuity Card Assessment of Visual Function in the Cryotherapy for Retinopathy of Prematurity Trial. Investigative Ophthalmology & Visual Science 31:1702-1708, 1990. Prematurity: One Year Outcome--Structure and Function. Archives of Ophthalmology 108:1408-1416, 1990. Schaffer DB, Tung B, Hardy RJ: Guidelines for Follow-up for ROP. In Flynn JT, Tasman W(eds): Retinopathy of Prematurity for the Clinician, Springer-Verlag New York, Inc., New York, 1990. Phelps DL, Brown DR, Tung B, Cassady G, McClead RE, Purohit DM, Palmer EA: 28-day Survival rates of 6676 neonates with Birth Weights of 1250 Grams or Less. Pediatrics 87:7-17, 1991. Hardy RJ, Davis BR, Palmer EA, Tung B: Statistical Considerations in the Early Termination of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Controlled Clinical Trials 12:293-303, 1991. Palmer EA, Hardy RJ, Davis BR, Stein MA, Mowery RL, Tung B, Phelps DL, Schaffer DB, Flynn JT, Phillips CL: Operational Aspects of Early Termination of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Controlled Clinical Trials 12:277-292, 1991. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, on behalf of the Cryotherapy for Retinopathy of Pre-maturity Cooperative Group: Incidence and Early Course of Retinopathy of Prematurity. Ophthalmology 98:1628-1640, 1991. Gilbert WS, Dobson V, Quinn GE, Reynolds J, Tung B, Flynn JT: The Correlation of Visual Function with Posterior Retinal Structure in Severe Retinopathy of Prematurity. Archives of Ophthalmology 110:625-631, 1992.

Page 4 Summers GC, Phelps DL, Tung B, Palmer EA: Ocular Cosmesis in Retinopathy of Prematurity. Archives of Ophthalmology 110:1092-1097, 1992. Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, Hardy RJ: Prognostic Factors in the Natural Course of Retinopathy of Prematurity (ROP). Ophthalmology 100:230-237, 1993. Prematurity: 3 1/2-Year Outcome--Structure and Function. Archives of Ophthalmology 111:339-344, 1993. Reynolds J, Dobson V, Quinn GE, Gilbert WS, Tung B, Robertson J, Flynn JT: Prediction of Visual Function in Eyes with Mild to Moderate Posterior Pole Residua of ROP. Archives of Ophthalmology 111:1050-1056, 1993. The natural ocular outcome of premature birth and retinopathy: status at one year. Archives of Ophthalmology 112:903-912, 1994. Dobson V, Quinn GE, Summer CG, Saunders RA, Phelps DL, Tung B, Palmer EA: Effect of Acute-phase Retinopathy of Prematurity on Grating Acuity Development in the very low Birth Weight Infants. Investigative Ophthalmology & Visual Science 35(13):4236-4244, 1994. Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD: Comparison of Recognition and Grating Acuity in very low Birth Weight Children with and without Retinal Residua of Retinopathy of Prematurity (ROP). Investigative Ophthalmology & Visual Science 36:692-702,1995. Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng KP, Buckley E: Early Retinal Vessel Development as a Factor in Retinopathy of Prematurity and its Functional Sequelae. Archives of Ophthalmology 114:150-154, 1996. Prematurity: Snellen Acuity and Structure Outcome at 5½ years. Archives of Ophthalmology 114:417-424, 1996. Quinn GE, Dobson V, Barr CC, Davis BR, Palmer EA, Robertson J, Summer CG, Trese MT, Tung B: Visual Acuity of Eyes after Vitrectomy for ROP: Follow-up at 5½ years. Ophthalmology 103:595-600, 1996.

Page 5 Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA: Visual Fields Measured with Double-Arc Perimetry in Eyes with Threshold Retinopathy of Prematurity (ROP) from the CRYO-ROP Trial. Ophthalmology 103:1432-1437, 1996. Dobson V, Quinn GE, Abramov I, Hardy RJ, Tung B, Siatkowski RM, Phelps DL, Palmer EA: Color Vision Measured with Pseudoisochromatic Plates at 5½ years in Eyes of Children from the CRYO-ROP Study. Investigative Ophthalmology & Visual Science 37:2467-2474, 1996. Saunders RA, Donohue M, Christmann LM, Pakalnis VA, Tung B, Hardy RJ, Phelps DL: Racial Variation in Retinopathy of Prematurity. Archives of Ophthalmology 115:604-608, 1997. Bremer L, Fellows RR, Palmer EA, Baker JD, Hardy RJ, Tung B, Roger GL: Strabismus in Premature Infants in the First Year of Life. Archives of Ophthalmology 116:329-333, 1998. Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA: Prevalence of Myopia between 3 Months and 5½ Years in Preterm Infants with and without Retinopathy of Prematurity Ophthalmology 105:1292-1300, 1998. Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B: The Incidence of Ophthalmological Interventions in children with Birth Weights Less Than 1251 grams. Results through 5½ Years Ophthalmology 105:1621-1627, 1998. Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B: Agreement Between Grating Acuity at Age 1 Year and Snellen Acuity at age 5½ years in the Pretern Child. Investigative Ophthalmology & VisualScience 40:496-503, 1999. Harvey EM, Dobson V, Tung B, Quinn GE, Hardy RJ: Interobserver Agreement for Grating Acuity and Letter Acuity Assessment in 1- to 5½- year-old with Severe Retinopathy of Prematurity. Investigative Ophthalmology & VisualScience 40:1565-1576 1999. LIGHT-ROP Cooperative Group: The Design of the Multicenter Study in Retinopathy of Prematurity: Journal of Pediatric Ophthalmology & Strabismus 36(5):257-263, 1999. Repka MX, Palmer EA, Tung B: Involution of Retinopathy of Prematurity. Archives of Ophthalmology 118(5):645-649,2000. Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead RE,

Page 6 Quinn GE, Reynolds JD, Hardy RJ, Palmer EA: Severity of Neonatal Retinopathy of Prematurity (ROP) is Predictive of Neurodevelopmental Functional Outcome at Age 5.5 Years. Pediatric 106:998-1005, 2000. Quinn GE, Dobson V, Siatkowski RM, Hardy RJ, Kivlin JD, Palmer EA, Phelps DL, Repka MX, Summers CG, Tung B, Chan W : Does Cryotherapy affect Refractive Error? Results from Treated and Control Eyes in the Cryotherapy for Retinopathy of Prematurity: Ophthalmology 108(2):343-347,2001. Ophthalmological Outcome at 10 years. Archives of Ophthalmology 119(8):1110-1118,2001. Effect of Ablative Cryotherapy for Threshold Retinopathy of Prematurity: Results of Goldmann Perimetry at age 10 years. Archives of Ophthalmology 119(8):1120-1125,2001. Contrast Sensitivity in Eyes with Threshold ROP from the CRYO-ROP Trial. Archives of Ophthalmology 119(8):1129-1233, 2001. Kennedy K, Fielder AR, Hardy RJ, Tung B, Gordon D, Reynolds JD for the LIGHT-ROP Cooperative Group, Reduced Lighting Does not Improve Medical Outcome in Very-Low-Weight Infants. Journal of Pediatrics 139(4):527-531,2001. Multicenter trial of cryotherapy for retinopathy of prematurity: Natural history ROP: Ocular outcome at 5½ years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120:595-599,2002. Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer DB, Tung B for the CRYO-ROP and LIGHT-ROP Cooperative Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 120:1470-1476,2002. Hardy RJ, Palmer EA, Dobson V, Summers CG, Phelps DL, Quinn GE, Good W, Tung B. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 121:1697-1701,2003. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity (ROP): results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121:1684-1696,2003.

Page 7 Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, Summers GS, Palmer EA on Behalf of the CRYO-ROP Cooperative Group. Health related quality of life at age 10 years in very-lowbirth-weight with and without severe retinopathy of prematurity. Arch Ophthalmol 122:1659-1666, 2004. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Fifteen-year Outcomes following Threshold Retinopathy of Prematurity: Final Results from the Multicenter Trial of Cryotherapy. Arch Ophthalmol 123:311-318, 2005. Early Treatment for Retinopathy of Prematurity Cooperative Group. The Incidence and Course of Retinopathy of Prematurity: Findings from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics 116;15-23, 2005. Davitt BV, Dobson V, Good WV, Hardy RJ, Quinn GE, Siatkowski RM, Summers CG, Tung B, on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence of Myopia at 9 Months in Infants with High-Risk Prethreshold Retinopathy of Prematurity: Results from the ETROP Trial. Ophthalmology 112(9);1564-1568,2005. Repka MX, Tung B, Good WV, Shapiro M, Capone A Jr, Baker JD, Barr CC, Phelps DL, van Heuven WAJ Outcome of Eyes Developing Retinal Detachment During the Early Treatment for Retinopathy of Prematurity Study (ETROP) Arch Ophthalmol, 124: 24 30, 2006. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Visual acuity at 10 Years in the CRYO-ROP Study Eyes: Effect of retinal residua of ROP. Arch Ophthalmol, 124;199-202, 2006. VanderVeen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ, Neely DE, Palmer EA, Steidl SM, Tung B, Good WV, MD; for the Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence and Course of Strabismus in the First Year of Life for Infants With Prethreshold Retinopathy of Prematurity Arch Ophthalmol, 124: 766-773, 2006. Group. The early treatment for retinopathy of prematurity study (ETROP): structural findings at 2 years of age. Br J Ophthalmol, 90:1378-1382, 2006.

Page 8 Hardy RJ, Good WV, Dobson V, Palmer EA, Tung B, Phelps DL, Shapiro MJ, van Heuven WAJ, on behalf of the ETROP Cooperative Group. The Early Treatment for Retinopathy of Prematurity Clinical Trial: Presentation by Subgroups versus Analysis within Subgroups. Br J Ophthalmol, 90:1341-1342, 2006. PMC1857474 Siatkowski RM, Dobson V, Quinn GE, Summers CG, Tung B: Severe Visual Impairment in Children with Mild or Moderate Residua Following Regressed Threshold ROP. Journal of AAPOS, 11(2):148-152, 2007. Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, Good WV on behalf of the ETROP Cooperative Group. Progression of Myopia in the Early Treatment for Retinopathy of Prematurity Study: Findings to 3 Years of Age. Ophthalmology, 115(6):1058-64, 2008. Davitt BV, Quinn GE, Dobson V, Quinn GE, Hardy RJ, Tung B, Good WV on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. Astigmatism in the Early Treatment for Retinopathy of Prematurity Study: Findings to 3 Years of Age. Ophthalmology 116:332-9, 2009. PMC2692212 Christiansen SP, Dobson V, Quinn GE, Good WV, Tung B, Hardy RJ, Hoffman RO, Reynolds JD, Rychwalski PJ, Shapiro MJ. Progression of Type 2 to Type 1 ROP in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128: 461-465, 2010. Group. Final Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128:E1-E9, 2010. Group. Final Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128:663-671, 2010. Wheeler DT, Dobson V, Chiang MF, Bremer DL, Gewolb IH, Phelps DL, Hardy RJ, Good WV, Fellows R, Tung B, Palmer EA. Retinopathy of Prematurity in Infants Weighing Less Than 500 Grams at Birth Enrolled in the Early Treatment for Retinopathy of Prematurity (ETROP) Study. Ophthalmol. January 4, 2011.

Page 9 Group. Visual Field Extend at Age 6 Years in Children who had High-Risk Prethreshold Retinopathy of Prematurity. Arch Ophthalmol. Accepted, 2010. Group. Grating Visual Acuity Results in the Early Treatment for Retinopathy Study. Arch Ophthalmol, Accepted, 2011.